SCHEMBL7673205

SCHEMBL7673205

Clc1ccc(Oc2sc3ccccc3c2Cl)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.44
▸ SLC6A2 P23975 3/20 0.44
▸ SLC6A3 Q01959 3/20 0.44
▸ MAPT P10636 2/20 0.44
▸ NR1I2 O75469 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TTR P02766 1/20 0.44
▸ PGR P06401 1/20 0.44
▸ HSP90AA1 P07900 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ HSPA5 P11021 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ CBR1 P16152 1/20 0.44
▸ TBXA2R P21731 1/20 0.44
▸ AGTR1 P30556 1/20 0.44
▸ PTGS1 P23219 1/20 0.43
▸ PTGS2 P35354 1/20 0.43
▸ SLC6A4 P31645 2/20 0.41
▸ RHEB Q15382 1/20 0.41
▸ CHRM1 P11229 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7670984 0.79 LOXL2 (0.43) KDM4EMAPTLMNALOXL2JAK2
SCHEMBL7668527 0.76 TRPA1 (0.45) SLC6A2SLC6A3SLC6A4LOXL2ALDH1A1
SCHEMBL7667320 0.76 LOXL2 (0.43) KDM4EMAPTLMNALOXL2ALDH1A1
SCHEMBL7661911 0.74 LOXL2 (0.42) KDM4ESLC6A3MAPTHPGDLOXL2
SCHEMBL7186092 0.71 TTR (0.75) SLC6A2SLC6A3MAPTNR1I2LMNA
SCHEMBL7662088 0.71 L3MBTL1 (0.40) KDM4EMAPTLMNAHPGDLOXL2
SCHEMBL7671893 0.71 LOXL2 (0.39) MAPTSLC6A4LOXL2ALDH1A1GAA
SCHEMBL7674113 0.71 ALOX5 (0.41) KDM4EMAPTLMNALOXL2ALDH1A1
SCHEMBL7662066 0.70 LOXL2 (0.41) KDM4EMAPTLMNAHPGDPTGS1
SCHEMBL7659816 0.70 ESR1 (0.44) MAPTPTGS2LOXL2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 — — US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 — — US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 — — US disclosed
Send feedback